LAB
Standard BioTools·NASDAQ
--
--(--)
--
--(--)
0.97 / 10
Underperform
The fundamental rating is 'Underperform' with a 1.0/10 score. Key concerns include a negative net income-to-revenue ratio (-0.1668) and a low current assets turnover ratio (0.1451), both in performance group 1. Revenue growth is also contracting YoY (-7.09%). Only Asset-MV and Net profit attributable to parent company shareholders / Net profit (%) show relative strength, but they are insufficient to offset broader weaknesses.
Analysis Checks(3/10)
Revenue-MV
Value-1.37
Score2/3
Weight-26.64%
1M Return3.00%
Value-1.37
Score2/3
Weight-26.64%
1M Return3.00%
Total operating revenue (YoY growth rate %)
Value-7.09
Score1/3
Weight16.69%
1M Return-2.56%
Value-7.09
Score1/3
Weight16.69%
1M Return-2.56%
Net income-Revenue
Value-0.17
Score1/3
Weight5.43%
1M Return-0.69%
Value-0.17
Score1/3
Weight5.43%
1M Return-0.69%
Current assets turnover ratio
Value0.15
Score0/3
Weight37.07%
1M Return-7.31%
Value0.15
Score0/3
Weight37.07%
1M Return-7.31%
Asset-MV
Value-0.50
Score2/3
Weight3.67%
1M Return-0.42%
Value-0.50
Score2/3
Weight3.67%
1M Return-0.42%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight12.18%
1M Return-1.63%
Value100.00
Score2/3
Weight12.18%
1M Return-1.63%
Net cash flow from operating activities / Operating revenue (%)
Value-118.88
Score1/3
Weight13.27%
1M Return-2.03%
Value-118.88
Score1/3
Weight13.27%
1M Return-2.03%
Net profit margin (%)
Value-153.05
Score1/3
Weight10.59%
1M Return-1.60%
Value-153.05
Score1/3
Weight10.59%
1M Return-1.60%
EBIT / Total operating revenue (%)
Value-133.53
Score1/3
Weight15.29%
1M Return-2.44%
Value-133.53
Score1/3
Weight15.29%
1M Return-2.44%
Net profit / Total operating revenue (%)
Value-153.05
Score1/3
Weight12.44%
1M Return-1.90%
Value-153.05
Score1/3
Weight12.44%
1M Return-1.90%
Revenue-MV
Value-1.37
Score2/3
Weight-26.64%
1M Return3.00%
Value-1.37
Score2/3
Weight-26.64%
1M Return3.00%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight12.18%
1M Return-1.63%
Value100.00
Score2/3
Weight12.18%
1M Return-1.63%
Total operating revenue (YoY growth rate %)
Value-7.09
Score1/3
Weight16.69%
1M Return-2.56%
Value-7.09
Score1/3
Weight16.69%
1M Return-2.56%
Net cash flow from operating activities / Operating revenue (%)
Value-118.88
Score1/3
Weight13.27%
1M Return-2.03%
Value-118.88
Score1/3
Weight13.27%
1M Return-2.03%
Net income-Revenue
Value-0.17
Score1/3
Weight5.43%
1M Return-0.69%
Value-0.17
Score1/3
Weight5.43%
1M Return-0.69%
Net profit margin (%)
Value-153.05
Score1/3
Weight10.59%
1M Return-1.60%
Value-153.05
Score1/3
Weight10.59%
1M Return-1.60%
Current assets turnover ratio
Value0.15
Score0/3
Weight37.07%
1M Return-7.31%
Value0.15
Score0/3
Weight37.07%
1M Return-7.31%
EBIT / Total operating revenue (%)
Value-133.53
Score1/3
Weight15.29%
1M Return-2.44%
Value-133.53
Score1/3
Weight15.29%
1M Return-2.44%
Asset-MV
Value-0.50
Score2/3
Weight3.67%
1M Return-0.42%
Value-0.50
Score2/3
Weight3.67%
1M Return-0.42%
Net profit / Total operating revenue (%)
Value-153.05
Score1/3
Weight12.44%
1M Return-1.90%
Value-153.05
Score1/3
Weight12.44%
1M Return-1.90%
Is LAB undervalued or overvalued?
- LAB scores 0.97/10 on fundamentals and holds a Premium valuation at present. Backed by its -21.62% ROE, -75.56% net margin, -4.02 P/E ratio, 1.21 P/B ratio, and 52.17% earnings growth, these metrics solidify its Underperform investment rating.
